Search Results 1081-1090 of 17369 for Hormone Transition

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Men with breast cancer: Your experience wth hormonal therapy? 24 ... Hormone therapy for breast cancer · Lumpectomy · Mammogram · Mastectomy · Molecular ...

  2. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

    Subjects with a history of autoimmune-related hypothyroidism on a stable dose of thyroid replacement hormone and subjects with controlled type 1 diabetes ...

  3. Stories For Change: Early Detection Can Save Lives - Mayo Clinic

    The purpose of this study is to evaluate the Stories for Change (S4C) Cancer Prevention digital storytelling intervention for acceptability and socio-behavioral ...

  4. Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE) - Mayo Clinic

    Hormone receptor and HER2 status are known. Exploratory Cohorts: Cohort 4: Stage IIb-III cutaneous melanoma or limited (resectable) stage IV melanoma ...

  5. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  6. Endocrinology - Clinical trials

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  7. Molecular Regulation of Muscle Glucose Metabolism - Mayo Clinic

    ... hormonal implant, intrauterine device, diaphragm with spermicide, condom with spermicide), or be surgically sterilized (i.e. bilateral tubal ligation ...

  8. Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The Investigational Device Uses Iron Oxide Nanoparticles Together With Non-Ionizing Alternating Magnetic Field To Generate Heat And Destroy Tumors - Mayo Clinic

    Received chemotherapy, radiotherapy or hormonal therapy within 14 days (before screening). 2. Received immunotherapy/biological therapy or any other ...

  9. Publications - Aziza Nassar, M.D., M.P.H. - Mayo Clinic

    ... Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative ... First Report of Management of Sequential Small Cell Transformation and ...

  10. Transcriptomic Changes Before And After Anti-tnf Therapy Utilizing Optimum Therapeutic Drug Levels - Mayo Clinic

    About this study. The purpose of this study is to evaluate infliximab drug levels and anti-infliximab antibody levels in HiSCR50/IHS4 responders versus ...